title: British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012.
authors.affiliation: Department of Dermatology, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK. vanessa.venning@ouh.nhs.uk
authors.forename: V A
authors.initials: VA
authors.lastname: Venning
authors.forename: K
authors.initials: K
authors.lastname: Taghipour
authors.forename: M F
authors.initials: MF
authors.lastname: Mohd Mustapa
authors.forename: A S
authors.initials: AS
authors.lastname: Highet
authors.forename: G
authors.initials: G
authors.lastname: Kirtschig
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D003880:Dermatology; D003937:Diagnosis, Differential; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010391:Pemphigoid, Bullous / Q000175:diagnosis / Q000188:drug therapy*; D012955:Societies, Medical; D006113:United Kingdom
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents